PROCEPT BioRobotics receives FDA 510(k) clearance for HYDROS Robotic System

PROCEPT BioRobotics Corp

HYDROS features FirstAssist AI for AI-powered treatment planning using real-world procedure data.
System integrates advanced image guidance, digital cystoscopy, and dual HD touchscreens.
Robotic resection uses heat-free waterjet to execute surgeon-defined treatment plans.
Streamlined workflow with single-footprint integrated tower, adjustable touchscreen, and instinctive software.
HYDROS brings next-generation Aquablation therapy, building on insights from over 50,000 procedures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.